Burosumab Biosimilar – Anti-FGF23 mAb – Research Grade

Reference:
Product nameBurosumab Biosimilar - Anti-FGF23 mAb - Research Grade
SourceDrugbank DB14012
SpeciesHomo sapiens
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsBurosumab,KRN-23,UX-023,FGF23,anti-FGF23
ReferencePX-TA1437
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Burosumab Biosimilar - Anti-FGF23 mAb - Research Grade

General information on Anti-FGF23[Homo sapiens] (Burosumab) Monoclonal Antibody

Burosumab is an human monoclonal IgG1 antibody that targets excess fibroblast growth factor 23 (FGF23) and has been investigated to treat children suffering from X-linked hypophosphatemic rickets.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Burosumab Biosimilar – Anti-FGF23 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Fibroblast growth factor 23(FGF23)
Antigen

Fibroblast growth factor 23(FGF23)

PX-P4768 221$
Human IgG1 LALA Isotype Control antibody (HyHEL-10)
Isotype Control

Human IgG1 LALA Isotype Control antibody (HyHEL-10)

PTX17885 189$
Stable Isotope Labelled Burosumab Biosimilar – Anti-FGF23 mAb – Research Grade
SIL

Stable Isotope Labelled Burosumab Biosimilar – Anti-FGF23 mAb – Research Grade

PX-TA1437-SIL 15750$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products